The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
Please provide your email address to receive an email when new articles are posted on . Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative ...
Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...
Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has introduced its all-encompassing contract ...
PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, is pleased to announce the ...
Recruiting and retaining patients for ophthalmology clinical trials presents unique challenges, from strict eligibility requirements to the burdens faced by those with vision impairments. In a Fierce ...
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
Nadia K. Waheed, MD, MPH, Appointed Chief Medical Officer; Peter K. Kaiser, MD, to Become Chief Development Officer; Andrea Gibson, PhD, Named Vice President, Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results